Engineered and Mimicked Extracellular Nanovesicles for Therapeutic Delivery

Verena Poinsot,Nathalie Pizzinat,Varravaddheay Ong-Meang

DOI: https://doi.org/10.3390/nano14070639

IF: 5.3

2024-04-06

Nanomaterials

Abstract:Exosomes are spherical extracellular nanovesicles with an endosomal origin and unilamellar lipid-bilayer structure with sizes ranging from 30 to 100 nm. They contain a large range of proteins, lipids, and nucleic acid species, depending on the state and origin of the extracellular vesicle (EV)-secreting cell. EVs’ function is to encapsulate part of the EV-producing cell content, to transport it through biological fluids to a targeted recipient, and to deliver their cargos specifically within the aimed recipient cells. Therefore, exosomes are considered to be potential biological drug-delivery systems that can stably deliver their cargo into targeted cells. Various cell-derived exosomes are produced for medical issues, but their use for therapeutic purposes still faces several problems. Some of these difficulties can be avoided by resorting to hemisynthetic approaches. We highlight here the uses of alternative exosome-mimes involving cell-membrane coatings on artificial nanocarriers or the hybridization between exosomes and liposomes. We also detail the drug-loading strategies deployed to make them drug-carrier systems and summarize the ongoing clinical trials involving exosomes or exosome-like structures. Finally, we summarize the open questions before considering exosome-like disposals for confident therapeutic delivery.

materials science, multidisciplinary,nanoscience & nanotechnology,physics, applied,chemistry

What problem does this paper attempt to address?

The paper attempts to address the application and challenges of extracellular nanovesicles (EVs) in therapeutic drug delivery. Specifically, the authors focus on the following aspects:

1. **Biological characteristics of exosomes**: Exosomes are nano-sized vesicles secreted by cells, with a single-layer lipid bilayer structure, ranging in size from 30 to 100 nanometers. They are rich in proteins, lipids, and nucleic acids, and the composition of these components depends on the state and origin of the secreting cells.

2. **Functions of exosomes**: The main function of exosomes is to encapsulate certain intracellular substances, transport them through biological fluids to target cells, and specifically deliver the cargo into the target cells. This process demonstrates the potential of exosomes as a prospective biological drug delivery system.

3. **Application of exosomes in drug delivery**: Although exosomes have good biocompatibility and low toxicity, they still face several issues in clinical applications, including insufficient yield, irreproducibility of the production process, and difficulties in isolation and purification.

4. **Alternative strategies**: To overcome these issues, the authors explore semi-synthetic methods, such as using cell membrane coatings of artificial nanocarriers or hybridization of exosomes with liposomes, to enhance the stability and drug loading efficiency of exosomes.

5. **Progress in clinical trials**: The paper also summarizes ongoing clinical trials involving exosomes or exosome-like structures, which mainly focus on the diagnosis and treatment of cancer, chronic diseases, and other pathological conditions.

In summary, the paper aims to explore the potential and challenges of exosomes as therapeutic drug delivery systems and proposes some alternative strategies to overcome these challenges.